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Hypercapnia Alters Expression of 
Immune Response, Nucleosome 
Assembly and Lipid Metabolism 
Genes in Differentiated Human 
Bronchial Epithelial Cells
S. Marina Casalino-Matsuda  1, Naizhen Wang1, Peder T. Ruhoff2, Hiroaki Matsuda3,4, 
Marie C. Nlend1,5, Aisha Nair1, Igal Szleifer3,6,7, Greg J. Beitel  8, Jacob I. Sznajder1 & 
Peter H. S. Sporn1,9
Hypercapnia, the elevation of CO2 in blood and tissues, commonly occurs in severe acute and chronic 
respiratory diseases, and is associated with increased risk of mortality. Recent studies have shown 
that hypercapnia adversely affects innate immunity, host defense, lung edema clearance and cell 
proliferation. Airway epithelial dysfunction is a feature of advanced lung disease, but the effect of 
hypercapnia on airway epithelium is unknown. Thus, in the current study we examined the effect 
of normoxic hypercapnia (20% CO2 for 24 h) vs normocapnia (5% CO2), on global gene expression in 
differentiated normal human airway epithelial cells. Gene expression was assessed on Affymetrix 
microarrays, and subjected to gene ontology analysis for biological process and cluster-network 
representation. We found that hypercapnia downregulated the expression of 183 genes and 
upregulated 126. Among these, major gene clusters linked to immune responses and nucleosome 
assembly were largely downregulated, while lipid metabolism genes were largely upregulated. The 
overwhelming majority of these genes were not previously known to be regulated by CO2. These 
changes in gene expression indicate the potential for hypercapnia to impact bronchial epithelial 
cell function in ways that may contribute to poor clinical outcomes in patients with severe acute or 
advanced chronic lung diseases.
Hypercapnia, the elevation of CO2 in blood and tissue, commonly occurs in patients with acute respiratory failure 
and chronic pulmonary disorders1–3. It has long been recognized that hypercapnia is associated with an increased 
risk of death in chronic obstructive pulmonary disease (COPD)4–8. Other studies have shown that hypercapnia 
is an independent risk factor for mortality in adults with community-acquired pneumonia9, children with ade-
noviral pneumonia10, cystic fibrosis patients awaiting lung transplantation11, and patients receiving mechanical 
ventilation for acute respiratory distress syndrome (ARDS)12.
Recent research has shed light on a variety of mechanisms by which hypercapnia may adversely affect clin-
ical outcomes in patients with lung disease. We and others have shown that elevated CO2 inhibits LPS-induced 
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expression of IL-6 and TNF in macrophages, fibroblasts and alveolar epithelial cells13,14. We also found that hyper-
capnia impairs bacterial clearance through inhibition of both phagocytosis and autophagy in macrophages13,15. 
Moreover, hypercapnia worsened lung injury and decreased bacterial clearance in mechanically ventilated rats 
with E. coli pneumonia16 and increased the mortality of Pseudomonas pneumonia in mice17. In the latter study, 
elevated CO2 decreased the early release of TNF, IL-6 and multiple chemokines into the lung, inhibited bacte-
rial phagocytosis and NADPH-oxidase-mediated reactive oxygen species generation by lung neutrophils, and 
increased bacterial loads in the lungs and other organs17. Hypercapnia was also shown to inhibit alveolar fluid 
clearance in the rat lung, which was due to downregulation of Na,K-ATPase activity caused by endocytosis of 
the enzyme due to activation of AMP-activated kinase and PKC-zeta18,19. Additionally, elevated CO2 inhibited 
proliferation of alveolar epithelial cells and lung fibroblasts, which resulted from mitochondrial dysfunction 
triggered by mirR-183-dependent downregulation of isocitrate mitochondrial dehydrogenase 2 (IDH2)20. Thus, 
hypercapnia adversely affects innate immune responses, host defense, lung edema clearance, and proliferation of 
cells required for lung repair. Notably, in almost all of the foregoing studies, elevated CO2 produced these effects 
independently of acidosis.
While the above studies have focused on the impact of hypercapnia on macrophages, neutrophils, fibroblasts, 
and alveolar epithelial cells, how elevated CO2 affects bronchial epithelial cells has not previously been investi-
gated. The airway epithelium is the first line of defense against inhaled pathogens and other noxious agents, and 
its integrity is critical for host defense and maintenance of lung homeostasis21,22. Also, diseases associated with 
hypercapnia including COPD, asthma, cystic fibrosis and ARDS are all characterized by airway epithelial dys-
function23–26. Thus, in the current study we examined the effect of hypercapnia on global gene expression in nor-
mal human bronchial epithelial (NHBE) cells that were differentiated at the air-liquid interface (ALI). We show 
that exposure for 24 h to normoxic hypercapnia (20% CO2), as opposed to normocapnia (5% CO2) downregulates 
genes linked to innate immunity, host defense, and nucleosome assembly and upregulates genes required for 
cholesterol biosynthesis and lipid metabolism. These changes in gene expression indicate the potential for hyper-
capnia to alter bronchial epithelial cell function in ways that may contribute to poor clinical outcomes in patients 
with severe acute or advanced chronic lung diseases.
Results
Differential gene expression induced by hypercapnia. To determine whether elevated CO2 induces 
transcriptional changes in airway epithelium, NHBE cells differentiated at ALI were exposed to hypercapnia (20% 
CO2) for 24 h or maintained in normocapnia (5% CO2) as a control, and global gene expression was analyzed 
using Affymetrix GeneChip Hybridization. Microarray global gene expression analysis revealed that hypercapnia 
significantly modified the expression of 309 genes ≥±1.4 fold (expressed as log2 [fold change]) with an adjusted 
P value ≤ 0.05. This represents only 1.5% of the 20,390 transcripts represented on the Affymetrix chip, indicating 
that the impact of elevated CO2 on gene expression is highly selective. The proportion of genes whose expres-
sion was significantly upregulated (126) or downregulated (183) in response to high CO2 is depicted in Fig. 1a. 
Differential gene expression is also represented as a volcano plot of log2 (fold change ratio) vs. −log10 (P values) 
(Fig. 1b) and as a heat map with hierarchical clustering (Supplementary Fig. 1a). The names and fold-changes 
for all genes downregulated or upregulated by ≥1.4 fold are listed in Supplementary Tables 1,2, respectively. 
These transcriptional changes cannot be attributed to cytotoxicity since exposure to 20% CO2 for 24 h caused no 
increase in LDH release from the cells (Supplementary Fig. 2).
Biological processes targeted by hypercapnia. Gene Ontology (GO) analysis showed that 
for hypercapnia-downregulated genes, the most enriched process was nucleosome assembly (Fig.  1c 
and Supplementary Fig.  1b), which includes multiple histone genes (Supplementary Fig.  1b). Other 
hypercapnia-downregulated processes include chemotaxis, cell surface receptor signaling, response to LPS, 
defense responses to bacteria, and cell adhesion (Fig. 1c). Specific CO2-downregulated genes associated with 
these processes are listed in Supplementary Fig. 1b. Among hypercapnia-upregulated genes, the most enriched 
processes involved lipid metabolism including cholesterol, isoprenoid, fatty acid and steroid biosynthesis, as well 
as oxidation-reduction, and negative regulation of translation initiation (Fig. 1c). Specific CO2-upregulated genes 
associated with some of these processes are listed in Supplementary Fig. 1b.
GO biological process-associated gene clusters targeted by hypercapnia. Major clusters from 
hypercapnia-downregulated genes are linked to immune response, nucleosome assembly, cell differentiation, 
oxidation reduction, and ion and lipid transport (Fig. 2). Clusters from upregulated genes induced by high CO2 
(Fig. 3) involve biological processes related to lipid metabolism, cholesterol biosynthesis, signal transduction, and 
transport. A number of these important clusters, labelled A-E in Figs 2 and 3, are analyzed in more detail in the 
following sections. Their corresponding gene lists are depicted in Figs 4,5, and Supplementary Fig. 3.
Hypercapnia differentially regulates genes associated with innate immunity and nucleosome 
assembly. Cluster A, represented in Fig. 4a, includes hypercapnia-regulated genes involved in signal trans-
duction, immune and inflammatory responses, and leukocyte chemotaxis. Notably, TLR4, multiple chemokines 
(CCL28, CXCL1, CXCL2, CXCL6, and CXCL14) and the IL-6 receptor gene (IL6R) were all downregulated by ele-
vated CO2. On the other hand, the IL-1 receptor like 1 gene (IL1RL1) was upregulated by hypercapnia. To validate 
the microarray results related to CO2-induced changes in key immunoregulatory genes, expression of CXCL1, 
CXCL14, CCL28, ILR6 and TLR4 was also assessed by qPCR. We found that these genes were all downregulated 
at levels similar to those in the microarray analysis (Fig. 4c). Indeed, the degree of CO2-induced downregulation 
of these transcripts assessed by qPCR and microarray was highly correlated (r2 = 0.7981).
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Figure 1. Hypercapnia induces transcriptional changes in NHBE cells. Global gene expression was assessed 
in ALI-differentiated NHBE cells after exposure to 5% CO2 (normocapnia) or 20% CO2 (hypercapnia) for 
24 h. (a) Pie chart indicating proportion of genes downregulated or upregulated by hypercapnia. (b) Volcano 
plot showing statistical significance (−log10 [P value]) plotted against log2 fold change for hypercapnia vs 
normocapnia. Plot indicates significantly upregulated genes (log2 [fold change]≥+0.5, adjusted P value ≤ 0.05) 
in red and downregulated genes (log2 [fold change]≤−0.5, adjusted P value ≤ 0.05) in blue. (c) Bars represent 
the top 10 GO biological processes downregulated (blue) and upregulated (red) by high CO2.
Figure 2. Networks of GO biological processes downregulated by hypercapnia. Gene clusters associated with 
GO biological processes containing five or more hypercapnia-downregulated genes and their intra- and inter-
cluster connections, as determined by unbiased analysis using Mathematica® v11.2.
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In addition, to determine whether downregulation of a key immunoregulatory transcript by hypercapnia 
was accompanied by a similar change in protein expression, we assessed expression of TLR4 protein in differen-
tiated NHBE cells. Immunofluorescence microscopy (Fig. 4d) and immunoblotting (Fig. 4e) both showed that 
exposure to 20% CO2 for 24 h decreased NHBE cell expression of TLR4 protein. Full-length blots are included 
in Supplementary Fig. 4. Taken together, these results suggest that hypercapnia would suppress airway epithelial 
innate immune response to microbial pathogens and other inflammatory stimuli.
Next, we analyzed cluster B, which includes hypercapnia-regulated genes that codify proteins involved in 
nucleosome assembly (Fig. 5a). The heat map in Fig. 5b shows that hypercapnia downregulates genes encoding 
multiple family members of the core histones H2A and H2B27, as well as the nucleosome assembly protein 1-like 1 
(NAP1L1), which regulates protein complex assembly, chromosome organization and DNA metabolism. The only 
upregulated gene in cluster B is H1F0, encoding histone H1, which is normally expressed in terminally differen-
tiated and slowly dividing cells. To validate the microarray data from cluster B, we performed qPCR for selected 
transcripts whose expression was significantly altered in the microarray analysis. Figure 5c shows that expression 
of the histone genes HIST1H2AC, HIST1H2BD, and HIST1H2BK was downregulated by hypercapnia as assessed 
by qPCR, again similar to the microarray results.
Other gene clusters impacted by hypercapnia. Cluster C (Supplementary Fig.  3) includes 
CO2-regulated genes associated with cholesterol biosynthesis (DHCR7, FDFT1, HMGCS1, IDI1) and transport 
(ABCA1, ABCC3, ABCC5), other lipid metabolism (ALDH3B1, ALDH3B2, ALOX15B, FADS1–2), and oxida-
tion reduction (several members of the cytochrome P450 family). Cluster D (Supplementary Fig. 3) includes 
hypercapnia-regulated genes involved in transcription (EGR3, JUN, RBM14) and DNA repair (BCCIP, CUL4A, 
RMB14). Genes in cluster E (Supplementary Fig. 3) regulate cell differentiation (CADM1, NRP2, NOTCH2NL 
and others), cell surface receptor signaling (EGFR, IFNAR1, IL6R and others) and apoptosis (BCL2L15, DAPL1, 
SEMA6A and others). The impact of elevated CO2 on expression of these genes would be expected to alter epithe-
lial metabolism and barrier function, as well as innate immune and inflammatory responses.
Discussion
To our knowledge, the present study is the first to investigate the impact of hypercapnia on global gene expression 
in airway epithelial cells. Of importance, we utilized primary NHBE cells cultured at ALI to achieve a differen-
tiated state closely resembling normal human bronchial epithelium. Our principal finding was that hypercapnia 
altered expression of a small number of specific genes (309 out of 20,390 transcripts assayed, or 1.5%) in differ-
entiated NHBE cells. Of these, 183 genes (59%) were downregulated, while 126 (41%) were upregulated. Thus, 
the effects of elevated CO2 are highly selective, involving both differential repression and differential activation 
of specific gene subsets. The overwhelming majority of these genes were not previously known to be regulated 
by CO2. Furthermore, gene ontogeny analysis showed enrichment of hypercapnia-regulated genes involved in 
a variety of fundamentally important cellular processes. Altering expression of genes related to these processes 
would be expected to impart functional changes in bronchial epithelial cells, which could in turn influence the 
pathophysiology and outcomes of many respiratory diseases.
Our data show that hypercapnia alters expression of multiple components of the innate immune system, 
including downregulation of the IL-6 receptor (IL6R); the neutrophil chemokines CXCL1, CXCL2 and CXCL628; 
the mucosal-associated chemokines CCL28 and CXCL1429–31 and importantly TLR4. Hypercapnia also upreg-
ulated CD55 and CD86, which bind virus at the cell surface32,33. While hypercapnia downregulated TLR4, it 
increased the expression of IL1RL1, which has been shown to inhibit TLR4 activation34. Of note, Schneberger et al. 
previously reported that hypercapnia reduced LPS-induced secretion of IL-6 and IL-8 in the airway epithe-
lial cell line BEAS-2B35. These observations are relevant because of the well-documented role of TLR4 in host 
Figure 3. Networks of GO biological processes upregulated by hypercapnia. Gene clusters associated with GO 
biological processes containing five or more hypercapnia-upregulated genes and their intra- and inter-cluster 
connections, as determined by unbiased analysis using Mathematica® v11.2.
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defense against multiple respiratory pathogens36–40. Interestingly, airway epithelial TLR4 expression was reduced 
in patients with severe COPD as compared to those with less severe COPD41, possibly due to hypercapnia in 
patients with advanced disease. Reduced expression of immune response genes was also seen in the lungs of new-
born mice exposed to moderate hypercapnia (8% CO2) for the first two weeks of life42. While the immune genes 
downregulated by hypercapnia in the newborn mice differed from those we found in NHBE cells, the mucosal 
immunity chemokine CXCL1443 was commonly downregulated in both systems. Taken together, these observa-
tions indicate that the airway epithelium is an important target for hypercapnic suppression of innate immune 
gene expression. This, along with the suppressive effects of elevated CO2 on macrophage, neutrophil, alveolar 
epithelial cell functions13–15,17–19 likely contributes to the deleterious impact of elevated CO2 on lung injury and 
host defense.
Another cluster impacted by hypercapnia includes genes related to nucleosome assembly, which also have 
antibacterial properties. The nucleosome consists of 145–147 base-pair-segments of DNA wrapped around a his-
tone octamer containing one (H3–H4)2 tetramer, two H2A–H2B dimers, and histone chaperones or linkers that 
facilitate nucleosome assembly44. Regulation of nucleosome assembly following DNA replication, DNA repair 
and gene transcription is critical for the maintenance of genome stability and epigenetic information44. Within 
this gene cluster, hypercapnia downregulated transcripts for the core histones H2A and H2B27, the histone chap-
erone NAP1L145, and the linker histone H127. Downregulation of histone gene expression can be triggered by 
DNA-damage or indirect inhibition of DNA synthesis46 and might lead to alterations of chromatin structure that 
would influence transcriptional regulation of many genes and even genome stability47. Exchange of core histones 
with histone variants might also alter the chemical nature and physical properties of the nucleosome, thereby 
affecting distinct cellular processes48. In addition, histones H2A and H2B also can inactivate endotoxin and func-
tion as antimicrobial proteins49,50.
We also found that elevated CO2 upregulated NHBE cell expression of cholesterol and fatty acid biosynthesis 
genes, while downregulating ATP-binding cassette (ABC) transporters, which promote the efflux of cholesterol 
and phospholipids from the cell51. Interestingly, enveloped viruses subvert preexisting lipids for viral entry and 
trafficking and also reprogram lipid synthesis and lipid distribution in lipid rafts to establish an optimal envi-
ronment for their replication, assembly and egress52. Furthermore, host defense against viral infection involves 
Figure 4. Hypercapnia alters expression of genes involved in innate immunity and host defense. ALI-
differentiated NHBE cells were exposed to normocapnia (NC) or hypercapnia (HC) for 24 h prior to analysis. 
(a) Cluster A genes altered by hypercapnia and their associated GO biological processes. (b) Heatmap and 
hierarchical clustering of gene expression profiles in normocapnia and hypercapnia. (c) CXCL1, CXCL14, 
CCL28, IL6R, and TLR4 mRNA expression levels were assessed by qPCR and expression in hypercapnia was 
expressed as fold change relative to normocapnia. Results shown are means ± SE; n = 3. (d) Representative 
fluorescence micrographs of NHBE cells double-stained for TLR4 (red) and the cilia marker acetylated tubulin 
(green), and counter stained with Hoechst (blue). Non immune control (NIC) cells stained without primary 
antibodies. (e) Immunoblotting of whole cell lysates for TLR4. Histogram shows densitometry of TLR4 
normalized to β-actin (loading control). Results shown are means ± SE; n = 3.
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interferon-mediated downregulation of sterol biosynthesis53. Thus, hypercapnia-induced cholesterol accumula-
tion might contribute to the entry, replication, and shedding of respiratory viruses in the airways.
As noted above, in a previous study, we showed that hypercapnia downregulates the TCA cycle enzyme 
IDH2, resulting in mitochondrial dysfunction and impaired proliferation of fibroblasts and A549 lung epithelial 
cells20. However, in the current study, hypercapnia did not alter IDH2 expression in NHBE cells, indicating that 
CO2-mediated regulation of gene expression is cell-type-specific. On the other hand, a number of genes involved 
in mitochondrial function were regulated by hypercapnia in NHBE cells. Among these, upregulated genes 
included acyl-CoA dehydrogenase short/branched chain (ACADSB) and acyl-CoA synthetase short chain family 
member 2 (ACSS2), which encode enzymes involved in fatty acid synthesis and oxidation54. Genes downregulated 
by elevated CO2 included gamma-butyretaine hydroxlase 1 (BBOX 1), which catalyzes synthesis of L-carnitine, an 
essential co-factor in beta-oxidation55; kynurenine 3-monooxygenase (KMO), an outer mitochondrial membrane 
protein that hydroxylates tryptophan to form kynurenine56; BCL2 interacting protein 3 (BNIP3), a BH3 domain 
protein with pro-apoptotic activity57; and mitochondrial assembly of ribosomal large subunit 1 (MALSU1), an 
Figure 5. Hypercapnia alters expression of genes involved in nucleosome assembly. ALI-differentiated NHBE 
cells were exposed to normocapnia (NC) or hypercapnia (HC) for 24 h prior to analysis. (a) Cluster B genes 
altered by hypercapnia and their associated GO biologic processes. (b) Hierarchical clustering of the gene 
expression profiles in normocapnia and hypercapnia. (c) HIST1H2AC, HIST1H2BD and HIST1H2BK mRNA 
expression assessed by qPCR and hypercapnia was expressed as fold change relative to normocapnia. Results 
shown are means ± SE; n = 3.
www.nature.com/scientificreports/
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inhibitor of translation at the mitochondrial ribosome58. The diverse activities of these genes indicate the potential 
for hypercapnia to disrupt multiple mitochondrial functions in NHBE cells.
While the current study does not reveal the molecular mechanism(s) underlying hypercapnia-induced changes 
in gene transcription, other recent work suggests a path to elucidating components of a putative CO2-induced sig-
naling pathway leading to inhibition of innate immune gene expression and impaired host defense. We previously 
reported that elevated CO2 inhibits expression of antimicrobial peptide genes and suppresses antibacterial host 
defense in Drosophila59, suggesting that the immunosuppressive effect of hypercapnia is evolutionarily conserved. 
Using a genome-wide RNAi screen, we identified a small number of genes whose expression is required for 
CO2-induced immunosuppression in Drosophila cells, and which are conserved in mammalian systems60. Flies 
deficient in of one these genes, a zinc finger homeodomain transcription factor known as zfh2, were protected 
from CO2-induced mortality associated with bacterial infection60. This opens up the opportunity to test whether 
orthologues of zfh2 and other genes identified in the Drosophila screen mediate hypercapnic immunosuppression 
in mice and ultimately in humans.
Alterations in expression of innate immune and other genes in airway epithelial cells may be of central impor-
tance in the CO2-induced increase in mortality of Pseudomonas pneumonia we previously observed in mice17. 
In addition, the suppressive effect of elevated CO2 on immune gene expression in the airway epithelium, along 
with similar effects on immune cells, suggest a reason why severe COPD and other lung disease associated with 
hypercapnia all carry a high risk of pulmonary infection. Bacterial and viral infections are a principal cause 
of acute COPD exacerbations61–64, which are linked to the need for hospitalization and to mortality65,66. Thus, 
CO2-induced alterations in airway epithelial gene expression may underlie the increase in mortality associated 
with hypercapnia in advanced COPD, as well as community-acquired pneumonia9, adenoviral lung infections10 
and cystic fibrosis11. It is notable in this regard that reducing hypercapnia with noninvasive ventilatory support 
has been shown to decrease hospital readmissions and mortality in patients with severe COPD67,68. Further inves-
tigation of the molecular mechanisms and mediators of CO2 effects on gene expression may reveal targets for 
pharmacologic intervention to prevent hypercapnic immune suppression in patients with advanced respiratory 
disease.
Methods
Primary Normal Human Bronchial Epithelial Cells. Primary NHBE cells isolated from airways of 
humans without known lung disease were obtained from a commercial source (Lonza). The cells were plated 
on collagen-coated plastic dishes, grown to confluence in BEGMTM Bronchial Epithelial Cell Growth Medium 
(Lonza), and passaged after enzyme dissociation with trypsin69. Cells from passage-3 were seeded onto 24-mm, 
0.4 μm pore size, polyester, transwell inserts (Corning) at 0.5 × 106 cells per insert (4.67 cm2) and cultured in a 
serum-free medium70, comprised of 1:1 mixture of BEBM (Lonza): DMEM (Mediatech), supplemented with 
hydrocortisone (0.5 μg/ml), insulin (5 μg/ml), transferrin (10 μg/ml), epinephrine (0.5 μg/ml), triiodothyronine 
(6.5 ng/ml), epidermal growth factor (0.5 ng/ml), retinoic acid (50 nM), bovine pituitary extract (0.4%), gen-
tamycin (50 μg/ml), and amphotericin B (50 ng/ml). After the cells reached confluence in submersion culture, 
the medium above the inserts was removed and the cells were maintained in ALI culture for two more weeks, at 
which point differentiation to a pseudostratified mucociliary epithelium with characteristics of airway epithelium 
in vivo was established69,71. Differentiation after ∼2 wk on ALI culture was confirmed by the presence of beating 
cilia and mucus production, as previously described72. Culture of NHBE cells up to the point of full differentiation 
was carried out in an atmosphere of humidified 5% CO2/95% air at 37 °C.
Hypercapnia Exposure. After differentiation, NHBE cells were cultured in ALI for an additional 24 h in 
humidified 20% CO2/21% O2/59% N2 (hypercapnia) or maintained in humidified 5% CO2/95% air (5% CO2/20% 
O2/75% N2; normocapnia), as control. The growth medium was pre-saturated with appropriate CO2 concentra-
tion for 4 h prior to the addition to the cells. The PCO2 and pH of the pre-saturated media were measured using 
a pHOx Plus Blood Gas Analyzer (Nova Biomedical Corp). For the normocapnia- and hypercapnia-equilibrated 
media, the PCO2s were 44 and 112 mmHg, and the corresponding pH values were 7.4 and 7.1 respectively.
Cytotoxicity Assay. To determine whether hypercapnia induces cytotoxicity, lactate dehydrogenase (LDH) 
release to the apical and basolateral compartments was assessed using a colorimetric Cytotoxicity Detection Kit 
(Roche) according to the manufacturer’s instructions. Absorbance at 490 nm was measured using a VersaMax 
Tunable Microplate Reader (Molecular Devices). Percent LDH release was calculated as the amount of LDH 
measured in the basolateral supernatant or apical wash divided by the total amount of LDH in the culture (LDH 
in cell lysates plus that measured in apical and basolateral compartments) times 100.
RNA Isolation and Affymetrix GeneChip Hybridization. Total RNA was isolated using the RNeasy 
Mini kit (Qiagen). Quality and quantity of each RNA sample were assessed using a 2100 BioAnalyzer (Agilent). 
RNA was hybridized to GeneChip® Human Genome U133 2.0 Plus Array (Affymetrix). A total of 6 chips, each 
hybridized to a cRNA from different normocapnic (n = 3) or hypercapnic (n = 3) NHBE cell cultures were used in 
this study. The U133 2.0 Plus Arrays contain probes for approximately 56,921 transcripts and variants, including 
over 45,000 well characterized human genes. Fluorescent images were detected in a GeneChip® Scanner 3000 and 
expression data were extracted using the GeneChip Operating System v 1.2 (Affymetrix).
Microarray Data Analysis. Differential gene expression between normocapnia and hypercapnia was 
assessed by a statistical linear model analysis using the BioConductor package limma73,74 (https://www.biocon-
ductor.org/help/faq/), in which an empirical Bayes method is used to moderate the standard errors of the esti-
mated log-fold changes of gene expression. The moderated t-statistic p-values derived from the limma analysis 
were further adjusted for multiple testing by Benjamini and Hochberg’s method75 to control false discovery rate 
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(FDR). Many genes whose expression signals were below background were defined as “absent”. Transcripts absent 
in all samples were filtered out, leaving 54,675 probes corresponding to 20,390 genes in the downstream analysis. 
The lists of differentially expressed genes were obtained by the FDR criteria of <0.05 and fold-change cutoff of 
>1.4. Differential gene expression in hypercapnia versus normocapnia was depicted in a pie chart, volcano plot 
of statistical significance (−log10 P value) plotted against log2 fold change, and hierarchical clustering by Pearson 
correlation represented as heat maps generated using Heatmapper76 and Gene-E (https://software.broadinstitute.
org/GENE-E/).
Over representation analysis (ORA) of gene ontology (GO) terms from biological processes of all genes down-
regulated or upregulated by hypercapnia were separately analyzed using the Gene Ontology Analysis InnateDB 
tool77 which utilizes a manually-curated knowledgebase of genes, proteins, interactions and signaling pathways 
involved in mammalian innate immune responses. Results from the Innate DB analysis were confirmed using 
GeneGo Metacore (Thomson Reuter), a separately curated database and pathway analysis tool. Microarray data 
have been deposited to the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus 
(GEO; http://www.ncbi.nlm.nih.gov/projects/geo) complied with MIAME standards (accession number 
GSE110362).
Network Ontology Analysis. Subsequent analysis of global expression changes and ontology network 
assessment on the differentially selected genes was performed using Mathematica® v11.2 (Wolfram Research, Inc., 
Mathematica, Version 11.2, Champaign, IL (2017)). Ontology groups were generated using inbuilt GenomeData, 
matching the annotated genes with pre-defined processes and intracellular functions. Two approaches were used 
for analysis of genome wide expression changes: unbiased measurements of intra-network gene expression and 
fold-change ranked segmentation. Unbiased intra-network changes were assessed for cellular processes that con-
tained at least five genes in the post-screen data. Mean-fold change, the variance of the fold-change, and Pearson 
correlation of expression were measured for each process. Intra-network heterogeneity of relative expression 
was measured by calculating the standard deviation of the relative expression for genes within any given onto-
logical process. For instance, if a gene was classified as belonging to both “Nucleosome Assembly” and “Signal 
Transduction”, it was assigned to both groups and a connection between these processes was indicated. To further 
understand the impact of hypercapnia-induced differential gene expression, cluster domains of GO biological 
processes containing 5 or more genes and with at least 4 connections were also generated using Mathematica® 
v11.2. These processes were broadly grouped based on gene function and by their connections.
Quantitative TaqMan Real-time RT-PCR. Total RNA was isolated from NHBE cells and first-strand 
cDNA was generated using MultiScribe™ MuLV reverse transcriptase (Applied Biosystems). The first-strand 
cDNA was used to quantitate the mRNA levels by TaqMan real-time PCR system (Applied Biosystems). The 
level of expression of eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was used as reference, and fold 
change of target genes was calculated by the ∆∆CT method78.
Immunofluorescence Staining for TLR4. After exposure to normocapnia (5% CO2) or hypercapnia (20% 
CO2) for 24 h, differentiated NHBE cells were fixed with ice-cold 50% acetone/50% methanol for 5 min. Cells 
were blocked in PBS containing 2% BSA and 0.1% triton X-100 then double-stained with 1:200 polyclonal rabbit 
anti-human TLR4 antibody (H-80, Santa Cruz Biotechnology) followed by 1:200 Alexa Fluor 555-conjugated 
goat-anti-rabbit IgG (red) (Invitrogen), and 1:500 monoclonal mouse anti-human acetylated tubulin antibody 
(Clone 6–11B-1, Sigma) followed by 1:200 Alexa fluor 488-conjugated goat anti-mouse IgG (green) (Invitrogen). 
Nuclei were identified by staining with 1 µg/ml Hoescht (blue) (Sigma). Images were obtained using a Nikon 
TE200 inverted fluorescence microscope (Nikon) equipped with a SPOT RT Monochrome Digital Camera 
(Diagnostic Instruments). All images were captured with the same gain and exposure time using Metamorph 
software.
Immunoblotting for TLR4. After exposure to normocapnia (5% CO2) or hypercapnia (20% CO2) for 24 h, 
differentiated NHBE cells were lysed in RIPA buffer (Santa Cruz Biotechnology) supplemented with PMSF, 
sodium orthovanadate and protease inhibitor cocktail. Lysate proteins (30 μg/well) were resolved by SDS/PAGE 
4–20% gradient gels and transferred to nitrocellulose (Bio-Rad Laboratories). Membranes were probed with pol-
yclonal rabbit anti-human TLR4 (H-80) antibody followed by HRP-conjugated anti-rabbit secondary antibody 
(Pierce). Blots were stripped and re-probed with monoclonal mouse anti-human β-actin (Abcam) followed by 
HRP-conjugated anti-mouse secondary antibody (Pierce) to confirm the equal loading. The signals were detected 
using enhanced chemiluminescence SuperSignal West Dura Substrate kit (Pierce). TLR4/βactin ratios were 
assessed using ImageJ79.
Statistical analysis. Data are presented as means ± SE. Differences between two groups were assessed using 
Student’s t test. Levene’s test was used to analyze the homogeneity of variances. Significance was accepted at 
p < 0.05.
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